Cargando…
Considerations in boosting COVID-19 vaccine immune responses
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437678/ https://www.ncbi.nlm.nih.gov/pubmed/34534516 http://dx.doi.org/10.1016/S0140-6736(21)02046-8 |
| _version_ | 1783752204411207680 |
|---|---|
| author | Krause, Philip R Fleming, Thomas R Peto, Richard Longini, Ira M Figueroa, J Peter Sterne, Jonathan A C Cravioto, Alejandro Rees, Helen Higgins, Julian P T Boutron, Isabelle Pan, Hongchao Gruber, Marion F Arora, Narendra Kazi, Fatema Gaspar, Rogerio Swaminathan, Soumya Ryan, Michael J Henao-Restrepo, Ana-Maria |
| author_facet | Krause, Philip R Fleming, Thomas R Peto, Richard Longini, Ira M Figueroa, J Peter Sterne, Jonathan A C Cravioto, Alejandro Rees, Helen Higgins, Julian P T Boutron, Isabelle Pan, Hongchao Gruber, Marion F Arora, Narendra Kazi, Fatema Gaspar, Rogerio Swaminathan, Soumya Ryan, Michael J Henao-Restrepo, Ana-Maria |
| author_sort | Krause, Philip R |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8437678 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84376782021-09-14 Considerations in boosting COVID-19 vaccine immune responses Krause, Philip R Fleming, Thomas R Peto, Richard Longini, Ira M Figueroa, J Peter Sterne, Jonathan A C Cravioto, Alejandro Rees, Helen Higgins, Julian P T Boutron, Isabelle Pan, Hongchao Gruber, Marion F Arora, Narendra Kazi, Fatema Gaspar, Rogerio Swaminathan, Soumya Ryan, Michael J Henao-Restrepo, Ana-Maria Lancet Viewpoint Published by Elsevier Ltd. 2021 2021-09-14 /pmc/articles/PMC8437678/ /pubmed/34534516 http://dx.doi.org/10.1016/S0140-6736(21)02046-8 Text en © 2021 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Viewpoint Krause, Philip R Fleming, Thomas R Peto, Richard Longini, Ira M Figueroa, J Peter Sterne, Jonathan A C Cravioto, Alejandro Rees, Helen Higgins, Julian P T Boutron, Isabelle Pan, Hongchao Gruber, Marion F Arora, Narendra Kazi, Fatema Gaspar, Rogerio Swaminathan, Soumya Ryan, Michael J Henao-Restrepo, Ana-Maria Considerations in boosting COVID-19 vaccine immune responses |
| title | Considerations in boosting COVID-19 vaccine immune responses |
| title_full | Considerations in boosting COVID-19 vaccine immune responses |
| title_fullStr | Considerations in boosting COVID-19 vaccine immune responses |
| title_full_unstemmed | Considerations in boosting COVID-19 vaccine immune responses |
| title_short | Considerations in boosting COVID-19 vaccine immune responses |
| title_sort | considerations in boosting covid-19 vaccine immune responses |
| topic | Viewpoint |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437678/ https://www.ncbi.nlm.nih.gov/pubmed/34534516 http://dx.doi.org/10.1016/S0140-6736(21)02046-8 |
| work_keys_str_mv | AT krausephilipr considerationsinboostingcovid19vaccineimmuneresponses AT flemingthomasr considerationsinboostingcovid19vaccineimmuneresponses AT petorichard considerationsinboostingcovid19vaccineimmuneresponses AT longiniiram considerationsinboostingcovid19vaccineimmuneresponses AT figueroajpeter considerationsinboostingcovid19vaccineimmuneresponses AT sternejonathanac considerationsinboostingcovid19vaccineimmuneresponses AT craviotoalejandro considerationsinboostingcovid19vaccineimmuneresponses AT reeshelen considerationsinboostingcovid19vaccineimmuneresponses AT higginsjulianpt considerationsinboostingcovid19vaccineimmuneresponses AT boutronisabelle considerationsinboostingcovid19vaccineimmuneresponses AT panhongchao considerationsinboostingcovid19vaccineimmuneresponses AT grubermarionf considerationsinboostingcovid19vaccineimmuneresponses AT aroranarendra considerationsinboostingcovid19vaccineimmuneresponses AT kazifatema considerationsinboostingcovid19vaccineimmuneresponses AT gasparrogerio considerationsinboostingcovid19vaccineimmuneresponses AT swaminathansoumya considerationsinboostingcovid19vaccineimmuneresponses AT ryanmichaelj considerationsinboostingcovid19vaccineimmuneresponses AT henaorestrepoanamaria considerationsinboostingcovid19vaccineimmuneresponses |